RaySearch Laboratories (Sweden) Performance
| RAY-B Stock | SEK 186.60 0.80 0.43% |
The company holds a Beta of 0.5, which implies possible diversification benefits within a given portfolio. As returns on the market increase, RaySearch Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding RaySearch Laboratories is expected to be smaller as well. At this point, RaySearch Laboratories has a negative expected return of -0.52%. Please make sure to check RaySearch Laboratories' standard deviation, jensen alpha, and the relationship between the coefficient of variation and information ratio , to decide if RaySearch Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days RaySearch Laboratories AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 168.7 M | |
| Total Cashflows From Investing Activities | -254.5 M |
RaySearch |
RaySearch Laboratories Relative Risk vs. Return Landscape
If you would invest 25,650 in RaySearch Laboratories AB on November 7, 2025 and sell it today you would lose (6,990) from holding RaySearch Laboratories AB or give up 27.25% of portfolio value over 90 days. RaySearch Laboratories AB is generating negative expected returns and assumes 2.1532% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than RaySearch, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
RaySearch Laboratories Target Price Odds to finish over Current Price
The tendency of RaySearch Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 186.60 | 90 days | 186.60 | close to 99 |
Based on a normal probability distribution, the odds of RaySearch Laboratories to move above the current price in 90 days from now is close to 99 (This RaySearch Laboratories AB probability density function shows the probability of RaySearch Stock to fall within a particular range of prices over 90 days) .
RaySearch Laboratories Price Density |
| Price |
Predictive Modules for RaySearch Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as RaySearch Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.RaySearch Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. RaySearch Laboratories is not an exception. The market had few large corrections towards the RaySearch Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold RaySearch Laboratories AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of RaySearch Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 0.50 | |
σ | Overall volatility | 11.99 | |
Ir | Information ratio | -0.09 |
RaySearch Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of RaySearch Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for RaySearch Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| RaySearch Laboratories generated a negative expected return over the last 90 days | |
| The company reported the revenue of 641.67 M. Net Loss for the year was (47.31 M) with profit before overhead, payroll, taxes, and interest of 591.28 M. | |
| About 56.0% of the company shares are owned by institutional investors |
RaySearch Laboratories Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of RaySearch Stock often depends not only on the future outlook of the current and potential RaySearch Laboratories' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. RaySearch Laboratories' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 102.5 M |
RaySearch Laboratories Fundamentals Growth
RaySearch Stock prices reflect investors' perceptions of the future prospects and financial health of RaySearch Laboratories, and RaySearch Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RaySearch Stock performance.
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 2.45 B | |||
| Shares Outstanding | 25.83 M | |||
| Price To Earning | 56.86 X | |||
| Price To Book | 3.16 X | |||
| Price To Sales | 2.85 X | |||
| Revenue | 641.67 M | |||
| EBITDA | 197.36 M | |||
| Cash And Equivalents | 102.53 M | |||
| Cash Per Share | 3.30 X | |||
| Total Debt | 491.9 M | |||
| Debt To Equity | 39.30 % | |||
| Book Value Per Share | 18.81 X | |||
| Cash Flow From Operations | 238.16 M | |||
| Earnings Per Share | (1.03) X | |||
| Total Asset | 1.74 B | |||
| Current Asset | 262 M | |||
| Current Liabilities | 80 M | |||
About RaySearch Laboratories Performance
Assessing RaySearch Laboratories' fundamental ratios provides investors with valuable insights into RaySearch Laboratories' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the RaySearch Laboratories is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
RaySearch Laboratories AB operates as a medical technology company that develops software solutions for cancer treatment in North America, Asia, Europe, and internationally. The company was founded in 2000 and is headquartered in Stockholm, Sweden. RaySearch Laboratories operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange. It employs 307 people.Things to note about RaySearch Laboratories performance evaluation
Checking the ongoing alerts about RaySearch Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for RaySearch Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RaySearch Laboratories generated a negative expected return over the last 90 days | |
| The company reported the revenue of 641.67 M. Net Loss for the year was (47.31 M) with profit before overhead, payroll, taxes, and interest of 591.28 M. | |
| About 56.0% of the company shares are owned by institutional investors |
- Analyzing RaySearch Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RaySearch Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining RaySearch Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RaySearch Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of RaySearch Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RaySearch Laboratories' stock. These opinions can provide insight into RaySearch Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for RaySearch Stock Analysis
When running RaySearch Laboratories' price analysis, check to measure RaySearch Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RaySearch Laboratories is operating at the current time. Most of RaySearch Laboratories' value examination focuses on studying past and present price action to predict the probability of RaySearch Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RaySearch Laboratories' price. Additionally, you may evaluate how the addition of RaySearch Laboratories to your portfolios can decrease your overall portfolio volatility.